Onco-Innovations Company Description

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology.

Onco-Innovations Limited is headquartered in Calgary, Canada.

Onco-Innovations Limited

Country	Canada
Industry	Biological Products, Except Diagnostic Substances
Employees	1
CEO	Thomas O’Shaughnessy

Contact Details

Address: 7th Street SW Calgary, British Columbia T2R 1A5 Canada
Phone	848-488-9277
Website	oncoinnovations.com

Stock Details

Ticker Symbol	ONCO
Exchange	Cboe Canada
Fiscal Year	May - April
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Thomas O’Shaughnessy	Chief Executive Officer
Nico Mah	Chief Financial Officer